The North America in-vitro colorectal cancer screening tests market is witnessing steady growth as healthcare systems strengthen colorectal cancer prevention and early-detection programs. Rising screening participation, increasing preference for non-invasive testing methods, and technological advances in molecular and biomarker-based diagnostics are contributing to regional demand. Growing...